Administration of amyloid β-peptides in the rat medial septum causes memory deficits: Reversal by SR 57746A, a non-peptide neurotrophic compound

Neuroscience Letters

Volumn 213, Issue 2, 1996, Pages 79-82

  Terranova, Jean Paul ^a   Kan, Jean Paul ^a   Storme, Jean Jacques ^a   Perreaut, Pierre ^a   Le Fur, Gérard ^a   Soubrié, Philippe ^a  

^a SANOFI   (France)

Author keywords

Amyloid peptides; Cholinergic neurons; Septum; Short term memory; Social recognition test; SR 57746A

Indexed keywords

AMYLOID BETA PROTEIN; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG; XALIPRODEN;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; MALE; MEMORY; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEPTUM NUCLEUS;

EID: 0030564998     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12859-7     Document Type: Article

References (23)

1. [1] Abe, E., Cassmenti, F., Giovannelli, L., Scali, C. and Pepeu, G., Administration of amyloid β peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo, Brain Res., 636 (1994) 162-164.
2. [2] Arisoe, N., Roias, R. and Pollard, H.B., Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminium, Proc. Natl. Acad. Sci. USA, 90 (1993) 567-571.
3. [3] Dantzer, R., Bluthe, R.M., Koob, G.F. and Le Moal, M., Modulation of social memory in male rats by neurohypophyseal peptides, Psychopharmacology, 91 (1987) 363-368.
4. + channels, Science, 264 (1994) 276-279.
5. [5] Flood, J.F., Morley, J.E. and Roberts, E., An amyloid β-protein fragment, Aβ(12-28), equipotently impairs post-training memory processing when injected into different limbic system structures, Brain Res., 663 (1994) 271-276.
6. [6] Fournier, J., Steinberg, R., Gauthier, T., Kesne, P.E., Guzzi, U., Coude, F.X., Bougault, I., Maffrand, J.P., Soubrie, P. and Le Fur, G., Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates, Neuroscience, 55 (1993) 629-641.
7. [7] Games, D., Khan, K.M., Sorisno, F.G., Keim, P.S., Davis, D.L., Bryant, K. and Lieberburg, I., Lack of Alzheimer pathology after β-amyloid protein injections in rat brain, Neurobiol. Aging, 13 (1992) 569-576.
8. [8] Giovannelli, L., Casamenti, F., Scali, C., Bartolini, L. and Pepeu, G., Differential effects of amyloid peptides β(1-40) and β(25-35) injections into the rat nucleus basalis, Neuroscience, 66 (1995) 781-792.
9. [9] Harkany, T., Lengyel, Z., Soos, K., Penke, B., Luiten, P.G.M. and Gulya, K., Cholinotoxic effects of β-amyloid (1-42) peptide on cortical projections of the rat nucleus basalis magnocellularis, Brain Res., 695 (1995) 71-75.
10. [10] Kowall, N.W., Besl, M.F., Busciglio, J., Duffy, L.K. and Yankner, B.A., An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P, Proc. Natl. Acad. Sci. USA, 88 (1991) 7247-7251.
11. [11] Kowall, N.W., McKee, A.C., Yankner, B.A. and Besl, M.F., In vivo neurotoxicity of β-amyloid (β(1-40)) and the β(25-35) fragment, Neurobiol. Aging, 13 (1992) 537-542.
12. 3H]acetylcholine from rat striatal slices, Brain Res., 252 (1982) 77-84.
13. [13] McEntee, W.J. and Crook, T.H., Cholinergic function in the aged brain: implications for treatment of memory impairments associated with aging, Behav. Pharmacol., 3 (1992) 327-336.
14. [14] Perio, A., Terranova, J.P., Worms, P., Bluthe, R.M., Dantzer, R. and Biziere, K., Specific modulation of social memory in rats by cholinomimetic and neotropic drugs, by benzodiazepine inverse agonists, but not by psychostimulants, Psychopharmacology, 97 (1989) 262-268.
15. [15] Pike, C.J., Walencewicz-Wasserman, A.J., Kosmoski, J., Cribbs, D.H., Glabe, C.G. and Cotman, C.W., Structure-activity analyses of β-amyloid peptides: contributions of the β(25-35) region to aggregation and neurotoxicity, J. Neurochem., 64 (1995) 253-265.
16. [16] Roux, S., Hubert, I., Wettstein, J.G., Soubrie, P., Le Fur, G. and Porsolt, R.D., Facilitating effects of SR 57746A on short-term memory in an operant delayed alternation task in aged rats, Drug Dev. Res., 35 (1995) 83-93.
17. [17] Rush, D.K., Aschmies, S. and Merriman, M.C., Intracerebral β-amyloid (25-35) produces tissue damage: is it neurotoxic?, Neurobiol. Aging, 13 (1992) 591-594.
18. [18] Schmidt-Kastner, R. and Freund, T.F., Selective vulnerability of the hippocampus in brain ischemia, Neuroscience, 40 (1991) 599-636.
19. [19] Selkoe, D.J., Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease, Annu. Rev. Cell Biol., 10 (1994) 373-403.
20. [20] Stein-Behrens, B., Adams, K., Yeh, M. and Sapolsky, R., Failure of β-amyloid protein fragment (25-35) to cause hippocampal damage in the rat, Neurobiol. Aging, 13 (1992) 577-579.
21. [21] Tariot, P.N., Alzheimer disease: an overview, Alzheimer Dis. Assoc. Disord., 8 (Suppl. 2)(1994) 4-11.
22. [22] Terranova, J.P., Perio, A., Worms, P., Le Fur, G. and Soubrie, P., Social olfactory recognition in rodents: deterioration with age, cerebral ischemia and septal lesion, Behav. Pharmacol., 5 (1994) 90-98.
23. 3H]hemicholinium-3 in the rat brain: a potentially selective marker for presynaptic cholinergic sites, Life Sci., 35 (1995) 2335-2343.